Adjudicating claims for COVID-19 vaccines, their administration and COVID-19 monoclonal antibodies
Beginning January 1, 2022, Medicare Advantage Organizations (MAOs) and Medicare-Medicaid Plans
(MMPs) are responsible for adjudicating claims for COVID-19 vaccines and their administration and for
COVID-19 monoclonal antibodies and their administration.
December 2021 Anthem Provider News and Important Updates - Colorado